SynerFuse™ Announces IDE Proof of Concept Study Data Presented at Minnesota Neuromodulation Symposium

Posted on by

–Study to Evaluate Safety and Tolerability of Simultaneous Implant of Spinal Fusion and Neuromodulation Devices in Chronic Lower Back Pain Patients EDEN PRAIRIE, Minn., April 24, 2023 /PRNewswire/ — Justin Zenanko, CEO of SynerFuse™, is proud to announce that Michael Park, M.D.,…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.